Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 January 2023 | Story Leonie Bolleurs | Photo Leonie Bolleurs
At the 31st Annual Conference of SAARMSTE, were from the left: Prof Loyiso Jita, Dean of the UFS Faculty of Education; Prof Dr Susanne Prediger, plenary speaker, Prof Francis Petersen, UFS Rector and Vice-Chancellor; Dr Maria Tsakeni, Head of the UFS Department of Mathematics, Natural Science and Technology Education and Conference Chair; Dr Tulsi Morar, SAARMSTE President; and Prof Mogege Mosimege, Research Chair in Mathematics Education and Director of Initial Teacher Education at the UFS.

The University of the Free State (UFS) hosted the 31st Annual Conference of the Southern African Association for Research in Mathematics, Science and Technology Education (SAARMSTE) on its Bloemfontein Campus from 17 to 19 January 2023.

After two years of hosting the SAARMSTE conference virtually, it was presented as a hybrid conference for the first time. In attendance were delegates from the continent, the USA, India, Australia, and Europe.

The conference theme was: Intersecting Research, Policy and Practice for a Sustainable Praxis in Mathematics, Science and Technology Education: New possibilities and directions for the post-COVID-19 Pandemic Era.

 

Sharing best practices and discussing common challenges

SAARMSTE President, Dr Tulsi Morar from the Nelson Mandela University, believes that the conference provided fertile ground for delegates to share best practices, to discuss common challenges experienced during the pandemic, and to celebrate how these challenges were overcome. "It is only through our reliance and strength that we have succeeded, and because of our experiences, we can grow and innovate to be better prepared for any further challenges," he said.

Opening the event was Prof Francis Petersen, Rector and Vice-Chancellor of the UFS. He said the conference provided meaningful discussions for the challenges the world has to solve, stating that with challenges also come possibilities.

“We live in a time of significant change in the realm of technology, which has an impact on the world of work. Graduates will need to change their thinking in the world of work. They need to understand the future world of work,” Prof Petersen stated.

He also touched on curriculum reform, saying that a critical challenge for South Africa's education system is the decolonisation of the curriculum. What is being taught must make meaningful sense in our context. “The UFS has made significant progress in curriculum transformation since 2016,” he added.

With delegates as well as speakers from other countries present at the conference, Prof Petersen also talked about the UFS’ Global Citizens initiative. He said no country can operate in isolation. We need to learn from each other to move forward as a collective. “It is also vital to deliver global citizens,” he said.

“The importance of the SAARMSTE conference cannot be overemphasised in our current education landscape. We need sustainable relationships to be developed at conferences such as these in order to ask questions, think differently, and renew ourselves,” he concluded, stating that the role of humanities and social sciences in society is critical and that SAARMSTE can add value in this context.

 

Thinking indigenously about Technology education and its implementation

Contributing to robust discussions on Science, Technology, Engineering and Mathematics education, three keynote speakers shared their views during the three-day conference.

Prof Dr Susanne Prediger, Director of the newly established DZLM, the German National Centre for Mathematics Teacher Education, delivered the first keynote address of the conference. She talked about Fostering students’ understanding of procedures and underlying basic concepts: Design research for mathematics classrooms and teacher professional development in the post-pandemic era.

She said that although providing students with rich and deep mathematical learning opportunities is a common request in Mathematics education, many students are still only exposed to superficial learning. According to her, this was aggravated by the school closures during the pandemic and will continue in the post-pandemic era if Mathematics teachers are not sufficiently supported and prepared.

The second plenary was delivered by Prof Mishack T Gumbo from the University of South Africa. He is a Research Professor of Indigenous Technology Knowledge Systems Education in the Department of Science and Technology Education. The title of his talk was: A relook into Technology Education: Raising a transformational issue, where he focused on education, specifically the curriculum of Technology Education as a school subject.

The third plenary was delivered by Dr Gillian Roehrig from the University of Minnesota in the United States. Dr Roehrig is known for her research that explores issues of professional development for K-12 Science teachers, with a focus on the implementation of integrated STEM learning environments and the induction and mentoring of beginning secondary Science teachers.

Her paper, titled The Hows and Whys of Integrated STEM Education, explored the development of a conceptual and curricular framework for integrated STEM, and the benefits of using interdisciplinary approaches to address the policy goals of preparing students as STEM-literate citizens and for the future STEM workforce.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept